Related Experiment Video
Updated: Aug 8, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
A pyrazolyl-thiazole derivative causes antinociception in mice
C R Prokopp1, M A Rubin, P D Sauzem
1Laboratório de Neurotoxicidade e Psicofarmacologia, Departamento de Química, Setor de Bioquímica, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, RS, Brasil.
Summary
This study shows that the pyrazolyl-thiazole derivative B50 effectively reduces pain in mice, acting similarly to NSAIDs. Its antinociceptive effects are dependent on specific chemical structures and are not opioid-related.
Area of Science:
- Pharmacology
- Medicinal Chemistry
Background:
- Pain management remains a significant challenge, necessitating the development of novel analgesic agents.
- Pyrazolyl-thiazole derivatives represent a class of compounds with potential therapeutic applications.
Purpose of the Study:
- To investigate the antinociceptive properties of a novel pyrazolyl-thiazole derivative, B50.
- To elucidate the mechanism of action and structure-activity relationships of B50.
Main Methods:
- Acetic acid-induced writhing assay and tail-immersion test in male albino Swiss mice.
- Administration of B50 at varying doses (8, 23, 80 micromol/kg) and naloxone to assess opioid receptor involvement.
- Structure-activity relationship analysis by modifying key substituents on the B50 molecule.
Main Results:
- B50 demonstrated dose-dependent antinociception in the acetic acid writhing assay, significantly reducing the number of writhes.
- B50 did not produce antinociception in the tail-immersion test, suggesting a non-opioid mechanism.
- Naloxone pretreatment blocked the antinociceptive effect of B50 in the writhing assay, indicating involvement of opioid pathways, contrary to initial assessment.
- Structural modifications, such as removal of the methyl group or substitution of the bromo group, abolished the antinociceptive activity.
- B50 did not affect spontaneous locomotion or rotarod performance, ruling out non-specific motor effects.
Conclusions:
- The pyrazolyl-thiazole derivative B50 exhibits significant antinociceptive effects in a chemical pain model in mice.
- The antinociceptive activity of B50 is dependent on specific structural features, including the methyl group on the thiazole ring and the bromo substituent on the phenyl ring.
- The observed antinociceptive profile suggests a complex mechanism potentially involving opioid pathways, despite its non-analgesic effect in a thermal pain test, and differentiates it from typical NSAIDs.
Related Concept Videos
01:44Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...